www.tyvaso.com Open in urlscan Pro
45.60.45.59  Public Scan

Form analysis
0 forms found in the DOM

Text Content

TYVASO DPI IS NOW APPROVED

Learn more

Skip to main content
 * Important Safety Information
 * Prescribing Information
    * TYVASO
    * TYVASO DPI

 * Instructions for Use
    * TYVASO
    * TYVASO DPI

 * The information contained in this section of the site is clinical in nature
   and specifically created for healthcare professionals. If you are not a US
   healthcare professional, please click CLOSE to return to the consumer section
   of the site.
   
   Close
   
   Yes, I am a US healthcare professional and would like to continue.
   
   Continue
   
   For US Healthcare Professionals

TYVASO and TYVASO DPI are approved for the treatment of pulmonary hypertension
associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the
ability to exercise.

SELECT A CONDITION

 * PH-ILD (WHO GROUP 3)
 * PAH (WHO GROUP 1)



 * ASK ABOUT PH-ILD
   
   Raise Questions
   
   Effects & Symptoms of PH-ILD
   
   How to Check for PH-ILD
   
   Taking Action

 * ABOUT TYVASO
   
   What is TYVASO?
   
   How TYVASO Works

 * WHY TAKE TYVASO?
   
   Walking Distance
   
   Heart Strain
   
   Risk of PH-ILD Getting Worse

 * TAKING TYVASO
   
   How to Take TYVASO
   
   TYVASO DPI
   
   TYVASO Nebulizer
   
   Safety

 * SUPPORT & RESOURCES
   
   Patient Support Program
   
   Specialty Pharmacy
   
   Cost Assistance
   
   Resources
   
   FAQs



Skip to main content

SELECT A CONDITION

 * PH-ILD (WHO GROUP 3)
 * PAH (WHO GROUP 1)



ASK ABOUT PH-ILD

 * Raise Questions
 * Effects & Symptoms of PH-ILD
 * How to Check for PH-ILD
 * Taking Action

ABOUT TYVASO

 * What is TYVASO?
 * How TYVASO Works

WHY TAKE TYVASO?

 * Walking Distance
 * Heart Strain
 * Risk of PH-ILD Getting Worse

TAKING TYVASO

 * How to Take TYVASO
 * TYVASO DPI
 * TYVASO Nebulizer
 * Safety

SUPPORT & RESOURCES

 * Patient Support Program
 * Specialty Pharmacy
 * Cost Assistance
 * Resources
 * FAQs

 * Important Safety Information

 * Prescribing Information
    * TYVASO
    * TYVASO DPI

 * Instructions for Use
    * TYVASO
    * TYVASO DPI

 * The information contained in this section of the site is clinical in nature
   and specifically created for healthcare professionals. If you are not a US
   healthcare professional, please click CLOSE to return to the consumer section
   of the site.
   
   Close
   
   Yes, I am a US healthcare professional and would like to continue.
   
   Continue
   
   For US Healthcare Professionals


RAISE YOUR CHANCE OF BEING MORE ACTIVE WITH FRIENDS AND FAMILY BY JOINING THE
RAISE THE QUESTIONS PROGRAM

No matter where you are in your journey, Coach Phil will provide the helpful
tips and educational resources you need to take action and be better prepared to
talk to your doctor about PH. Learn more about the program
By answering the next couple of questions, you will help us ensure that you get
the educational information and support that is right for you based on where you
are on your personal lung health journey.


WHAT YOU CAN EXPECT

Tips from Coach Phil to help guide discussions with your doctor

Resources to help prepare you for talking to your doctor

Upon joining you can download a brochure, for in depth information about PH-ILD

Please provide your contact information below, after you do so, you will receive
a few more questions that will help us ensure you get the educational
information and support that is right for you.


PRIVACY

By clicking the SUBMIT button, I understand that I am giving United Therapeutics
Corporation and its affiliates and business partners permission to use my
personal information to provide me with information related to the TYVASO
Support Program, as well as treatment options and services provided by United
Therapeutics. I understand that United Therapeutics and its contractors will not
sell or rent my personal information. I understand I may revoke my permission at
any time by clicking the unsubscribe link at the bottom of the page. For more
information, please read the Privacy Policy.




IMPORTANT SAFETY
INFORMATION


BEFORE YOU TAKE TYVASO OR TYVASO DPI, TELL YOUR HEALTHCARE PROVIDER ABOUT ALL OF
YOUR MEDICAL CONDITIONS, INCLUDING IF YOU:

 * Have low blood pressure
 * Have or have had bleeding problems

EXPAND




IMPORTANT SAFETY
INFORMATION

COLLAPSE



BEFORE YOU TAKE TYVASO OR TYVASO DPI, TELL YOUR HEALTHCARE PROVIDER ABOUT ALL OF
YOUR MEDICAL CONDITIONS, INCLUDING IF YOU:

 * Have low blood pressure
 * Have or have had bleeding problems
 * Have asthma or chronic obstructive pulmonary disease (COPD)
 * Are pregnant or plan to become pregnant. It is not known if either product
   will harm your unborn baby.
 * Are breastfeeding or plan to breastfeed. It is not known if either product
   passes into your breast milk. Talk to your healthcare provider about the best
   way to feed your baby during treatment.


TELL YOUR HEALTHCARE PROVIDER ABOUT ALL OF THE MEDICINES YOU TAKE, INCLUDING
PRESCRIPTION AND OVER-THE-COUNTER MEDICINES, VITAMINS, AND HERBAL SUPPLEMENTS.
EITHER PRODUCT AND OTHER MEDICINES MAY AFFECT EACH OTHER.


ESPECIALLY TELL YOUR HEALTHCARE PROVIDER IF YOU TAKE:

 * Medicines used to treat high blood pressure or heart disease
 * Medicines that decrease blood clotting (anticoagulants)
 * Water pills (diuretics)
 * Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)


WHAT ARE THE POSSIBLE SIDE EFFECTS OF TYVASO OR TYVASO DPI?

Both products can cause serious side effects, including:

 * Low blood pressure (symptomatic hypotension). If you have low blood pressure,
   either product may lower your blood pressure more.
 * Bleeding problems. Either product may increase the risk of bleeding,
   especially in people who take blood thinners (anticoagulants).

The most common side effects of both products are cough, headache, throat
irritation and pain, nausea, reddening of the face and neck (flushing), fainting
or loss of consciousness, dizziness, diarrhea, and shortness of breath. Like
other inhaled prostaglandins, you may have trouble breathing after taking TYVASO
or TYVASO DPI because it may cause the muscles around your airway to tighten
(bronchospasm). These are not all the possible side effects. Call your doctor
for medical advice about side effects or if you have trouble breathing.

You may report side effects to the FDA at 


YOU ARE NOW LEAVING THE TYVASO.COM WEBSITE

This link will take you to a site maintained by a third party who is solely
responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return
to www.TYVASO.com.

CLOSE
CONTINUE

www.fda.gov/MedWatch

or call 1-800-FDA-1088.




WHAT ARE TYVASO AND TYVASO DPI?

TYVASO (treprostinil) Inhalation Solution and TYVASO DPI (treprostinil)
Inhalation Powder are prescription medicines used in adults to treat:

 * Pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood
   pressure in the arteries of your lungs. TYVASO or TYVASO DPI can improve the
   ability to exercise. Your ability to exercise decreases 4 hours after taking
   TYVASO or TYVASO DPI. It is not known if TYVASO or TYVASO DPI is safe and
   effective in children under 18 years of age.
 * Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO
   Group 3), which is high blood pressure in the lungs due to inflammation and
   sometimes scarring in the lungs. TYVASO or TYVASO DPI can improve the ability
   to exercise.

The risk information provided here is not comprehensive. To learn more about
TYVASO or TYVASO DPI, talk with your healthcare provider. Please see Full
Prescribing Information for TYVASO or TYVASO DPI, Instructions for Use manuals
for TD-100 and TD-300 TYVASO® Inhalation System and TYVASO DPI™ Inhalation
Powder, and additional information at www.TYVASO.com or call 1-877-UNITHER
(1-877-864-8437).


TYVISIconMAY2022



This site is intended for use by US residents only.

Drug Discard Program Privacy Policy Terms of Use Contact Us Site Map

This site is intended for use by US residents only.

TYVASO and TYVASO DPI are registered trademarks of United Therapeutics
Corporation.

All other brands are trademarks of their respective owners. The makers of these
brands are not affiliated with and do not endorse United Therapeutics or its
products.

© 2024 United Therapeutics Corporation. All rights reserved. US-TYV-0821